You are viewing the site in preview mode

Skip to main content

Table 2 Basic information of different mediastinal lesions and CTCs levels in the whole cohort

From: A deep learning model combining circulating tumor cells and radiological features in the multi-classification of mediastinal lesions in comparison with thoracic surgeons: a large-scale retrospective study

Characteristics

Training cohort

n = 434

Validation cohort

n = 288

Test cohort

n = 352

CTCs level (pg/ml)

Benign

 Cyst

162

54

90

10.38 ± 4.44

 Granuloma

3

6

14

13.24 ± 5.57

 Mature teratoma

8

7

3

9.85 ± 2.08

 Schwannoma

32

17

34

11.97 ± 5.29

 Fibroma

11

4

10

14.77 ± 5.52

 Hemangioma

4

2

5

11.22 ± 2.83

 Lipoma

10

3

6

12.73 ± 4.39

Malignant

 Type A thymoma

9

15

21

11.13 ± 4.32

 Type AB thymoma

42

31

39

13.78 ± 6.51

 Type B1 thymoma

15

29

26

14.84 ± 3.04

 Type B2 thymoma

29

21

15

12.43 ± 6.23

 Type B3 thymoma

13

10

13

14.04 ± 2.78

 Mixed thymoma

13

19

17

13.50 ± 7.13

 TSCC

28

13

18

15.89 ± 7.75

 Immature teratoma

7

9

4

14.38 ± 5.42

 MALT

4

5

3

21.66 ± 4.09

 Carcinoid

2

4

5

9.86 ± 0.67

 Lymphoma

18

22

14

16.25 ± 6.36

 Metastatic tumor

5

3

4

11.38 ± 5.81

Others

19

14

11

16.33 ± 4.62

  1. TSCC Thymic squamous cell carcinoma, MALT Mucosa-associated lymphoid tissue, Others Not specified lesions, CTCs Circulating tumor cells
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us